Company intelligence / Profile preview

Emona Biopharma

Ljubljana, Slovenia

Ownership: Private
Development stage: Other

Overview

Emona Biopharma is a GMP-certified pharmaceutical company focused on the development, out-licensing, and supply of generic and value-added generic medicines for the European market. The company supports registration and marketing partners with full EU CTD dossiers and is expanding into data-driven development of synergistic drug combinations through partnerships[1][2][3][5][6].

Modalities: Small molecule
Industry: Biotech

Partnerships

Keystonemab

Beyond the preview

Go deeper on Emona Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emona Biopharma.

Explore the full profile